Published in J Clin Microbiol on July 09, 2014
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations. Clin Med Insights Circ Respir Pulm Med (2015) 0.84
Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death. PLoS One (2015) 0.82
Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia. J Clin Microbiol (2015) 0.77
Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii. J Clin Microbiol (2015) 0.76
Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience. J Clin Diagn Res (2017) 0.75
Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study. BMC Infect Dis (2016) 0.75
Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients. J Clin Microbiol (2016) 0.75
Comparison of quantitative real-time PCR and direct immunofluorescence for the detection of Pneumocystis jirovecii. PLoS One (2017) 0.75
Pneumocystis pneumonia. N Engl J Med (2004) 5.86
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis (2006) 2.21
Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis (2002) 2.20
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc (2007) 1.73
Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev (2012) 1.68
Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol (2002) 1.56
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant (2011) 1.56
Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect (2011) 1.47
Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clin Infect Dis (2010) 1.41
Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest (2009) 1.38
Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) (2012) 1.21
A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii. Clin Infect Dis (2012) 1.10
Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother (2012) 1.09
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol (2011) 1.08
Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J Clin Microbiol (2011) 1.04
Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol (2005) 1.04
Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol (2013) 1.03
Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J Microbiol Methods (2008) 1.02
Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy. Mod Rheumatol (2005) 1.02
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J (2011) 1.00
Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays. Diagn Microbiol Infect Dis (2007) 1.00
Real time quantitative PCR assay for Pneumocystis jirovecii detection. J Eukaryot Microbiol (2003) 0.97
Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients. Eur J Clin Microbiol Infect Dis (2013) 0.95
Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect (2011) 0.95
Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization. J Clin Microbiol (2013) 0.93
Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease. Immunol Res (2011) 0.93
Which patients should be tested for viruses on bronchoalveolar lavage fluid? Eur J Clin Microbiol Infect Dis (2012) 0.90
Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One (2013) 0.89
Pneumocystis jirovecii colonization among renal transplant recipients. Nephrology (Carlton) (2013) 0.89
Pneumocystosis: a network survey in the Paris area 2003-2008. Eur J Clin Microbiol Infect Dis (2011) 0.85
Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: prevalence, risk factors of colonization and outcome. Rheumatology (Oxford) (2010) 0.85
A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. J Rheumatol (2009) 0.85
Possible nosocomial transmission of Pneumocystis jirovecii. Emerg Infect Dis (2012) 0.84
Pneumocystis jirovecii colonization in patients treated with infliximab. Eur J Clin Invest (2010) 0.84
Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia. Med Mycol (2011) 0.83
Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii. J Clin Microbiol (2011) 0.83
Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia. Eur J Clin Microbiol Infect Dis (2012) 0.81
Clinical significance of Pneumocystis jiroveci in patients with active tuberculosis. Diagn Microbiol Infect Dis (2013) 0.80
Evidence of airborne excretion of Pneumocystis carinii during infection in immunocompetent rats. Lung involvement and antibody response. PLoS One (2013) 0.79
Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity? Multidiscip Respir Med (2012) 0.77